Your browser doesn't support javascript.
loading
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells.
Chen, Shaokui; Li, Ruixin; Chen, Yibo; Chou, Chon-Kit; Zhang, Zhexuan; Yang, Yang; Liao, Ping; Wang, Qingqing; Chen, Xin.
Afiliación
  • Chen S; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Li R; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Chen Y; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Chou CK; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Zhang Z; College of Science, Hunan University of Technology and Business, Changsha 410205, China.
  • Yang Y; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Liao P; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China.
  • Wang Q; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Chen X; Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, 999078, Macao Special Administrative Region of China, China; Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau, 999078, Macao Special Adminis
Biomed Pharmacother ; 151: 113187, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35676787
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Apigenina / Receptores Tipo II del Factor de Necrosis Tumoral / Glucuronatos / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Apigenina / Receptores Tipo II del Factor de Necrosis Tumoral / Glucuronatos / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article